MedPath

Stanford Kids CAMP Study

Not Applicable
Conditions
Obesity
Type-2 Diabetes Mellitus
Pre-diabetes
Interventions
Other: Remote Monitoring Program
Registration Number
NCT05380817
Lead Sponsor
Stanford University
Brief Summary

The Stanford Kids CAMP study aims to evaluate the feasibility of enrolling minority participants in school age children (5-13 years old) in a community summer camp setting along with the efficiency by which each participant's biologic specimens are collected. Using remote monitoring technologies and through partnering with community-based organizations, the investigators hypothesize that an increase in underrepresented minority participation in a clinical trial that is greater than the national average is possible.

Detailed Description

The proposed study is an outpatient prospective, open-label clinical trial comparing 2 groups: Group 1 (aka BAWSI Camp): the Dexcom G6 Pro Continuous Glucose Monitor and the accelerometer and mobile connected device, Group 2 (aka YMCA of Silicon Valley Camp): the Abbott FreeStyle Libre 2 Continuous Glucose Monitor and the accelerometer and mobile connected device. Eligible subjects will be enrolled to each cohort based on their participation in the specific YMCA camp site.

The investigators will study up to 100 minority school-age children (5 - 13 years old) in the San Francisco Bay Area a 5-day summer camp. The study will be split in 2 sequential phases: (A) the BAWSI camp, (B) the YMCA of Silicon Valley camp, following a repeated measures design with the 5-day camp being followed by 5 - 9 days at home, under parental supervision. Study participants will be divided in two equal groups at each site with each wearing the specific manufacturers continuous glucose monitoring device.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 5-13 years of age.
  • Avoidance of acetaminophen-containing medications (i.e. Tylenol) while wearing the continuous glucose monitor.
  • Willingness to wear a continuous glucose sensor and physiological monitor for the duration of the study.
  • A parent/caregiver is available for system training and will commit to be the main responsible person for the use of the monitoring system at home.
Read More
Exclusion Criteria
  • Have a condition limiting their participation in the interventions (e.g., unable to participate in routine physical education classes at school, requiring oxygen supplementation for exertion, developmental or physical disability preventing participation in interventions, children or parents/guardians who cannot medically participate in mild dietary restrictions and/or increased physical activity for any reason).
  • Have a condition limiting participation in the assessments (child or primary caregiver not able to read surveys in English or Spanish, child two or more grade levels delayed in school for reading and writing in her native language).
  • Are unable to read, understand or complete informed consent in English or Spanish.
  • Are deemed to have another characteristic that makes them unsuitable for participation in the study in the judgment of the Principal Investigators.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BAWSI GroupRemote Monitoring ProgramBy partnering with a community sports club (BAWSI), will the partnership recruitment model be effective in enrolling minority children.
YMCA of Silicon Valley GroupRemote Monitoring ProgramBy partnering with a community organization (YMCA of Silicon Valley), will the partnership recruitment model be effective in enrolling minority children.
Primary Outcome Measures
NameTimeMethod
Percentage of underrepresented minority participants enrolledBaseline (prior to arrival at camp)

Percentage of underrepresented minority participants enrolled compared to the U.S. national average.

Secondary Outcome Measures
NameTimeMethod
At-home urine specimen collectionVisit 1, Visit 3 (collected on days 1 and 5)

Percentage of enrolled participants who complete at home urine sample collection and bring the sample with them to camp.

Continuous patient monitoring performanceBaseline through Visit 6 (days 1 though 14)

Percentage of total study time children were monitored using glucose and accelerometry devices

Duration of initial participant screeningVisit 1 (day 1, up to 60 minutes for screening)

Average duration of time to screen enrolled subjects on Day 1 of summer camp.

Report of issues and concerns during at-home monitoring periodVisit 4, Visit 6 (days 6 and 14, up to 30 minutes to complete survey)

# of telephone reported incidents and questions during at-home monitoring period.

Physical activity measured by accelerometryBaseline through Visit 6 (days 1 through 14)

Garmin Vivofit 4 total and after camp physical activity and sedentary behavior

Participant perceived use of study technologyVisit 6 (day 14, up to 15 minutes to complete survey)

Percentage of survey responses

Number of patient reported device related issuesVisit 1, Visit 2, Visit 3 (days 1 though 5)

This measure is intended to evaluate study device performance during summer camp

Trial Locations

Locations (1)

Stanford University

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath